RNAZ vs. BKNG

Last updated Jun 4, 2026

RNAZ (Transcode Therapeutics Inc) and BKNG (Booking Holdings Inc.) are both stocks. RNAZ operates in Biotechnology (Healthcare), while BKNG operates in Travel Services (Consumer Cyclical). Over the past 3 years, RNAZ returned -96.74%/yr vs 16.92%/yr for BKNG. At a 0.11 correlation, their price movements are largely independent.

Performance

RNAZ vs. BKNG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Transcode Therapeutics Inc (RNAZ) and Booking Holdings Inc. (BKNG). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, RNAZ achieves a -26.21% return, which is significantly lower than BKNG's -22.90% return.

RNAZ

• 1D: -4.64%
• 1M: -34.88%
• YTD: -26.21%
• 6M: -40.07%
• 1Y: -28.26%
• 3Y*: -96.74%
• 5Y*: —
• 10Y*: —

BKNG

• 1D: -1.45%
• 1M: -0.48%
• YTD: -22.90%
• 6M: -18.04%
• 1Y: -24.18%
• 3Y*: 16.92%
• 5Y*: 12.63%
• 10Y*: 12.42%

*Multi-year figures are annualized to reflect compound growth (CAGR)

RNAZ vs. BKNG - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
RNAZ Transcode Therapeutics Inc	-26.21%	-92.76%	-98.45%	-98.78%	-73.50%	-36.50%
BKNG Booking Holdings Inc.	-22.90%	8.59%	41.31%	76.02%	-16.00%	10.87%

Correlation

The correlation between RNAZ and BKNG is -0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.01
Correlation (3Y) Calculated over the trailing 3-year period	0.04
Correlation (All Time) Calculated using the full available price history since Jul 9, 2021	0.11

The correlation between RNAZ and BKNG shifts across timeframes, from -0.01 (1 year) to 0.11 (all time), reflecting how their relationship changes across market environments.

Fundamentals

EPS RNAZ : -$32.55 BKNG : $7.60
Total Revenue (TTM) RNAZ : $0.00 BKNG : $27.69B
Gross Profit (TTM) RNAZ : -$69.40K BKNG : $22.16B
EBITDA (TTM) RNAZ : -$26.93M BKNG : $9.27B

Return for Risk

RNAZ vs. BKNG — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RNAZ

RNAZ Risk / Return Rank: 29
RNAZ Sharpe Ratio Rank: 28
RNAZ Sortino Ratio Rank: 33
RNAZ Omega Ratio Rank: 32
RNAZ Calmar Ratio Rank: 26
RNAZ Martin Ratio Rank: 26

BKNG

BKNG Risk / Return Rank: 11
BKNG Sharpe Ratio Rank: 9
BKNG Sortino Ratio Rank: 12
BKNG Omega Ratio Rank: 12
BKNG Calmar Ratio Rank: 13
BKNG Martin Ratio Rank: 7

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RNAZ vs. BKNG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Transcode Therapeutics Inc (RNAZ) and Booking Holdings Inc. (BKNG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	RNAZ	BKNG	Difference
Sharpe ratio: Return per unit of total volatility	-0.32	-0.76	+0.45
Sortino ratio: Return per unit of downside risk	0.09	-0.96	+1.05
Omega ratio: Gain probability vs. loss probability	1.01	0.88	+0.13
Calmar ratio: Return relative to maximum drawdown	-0.42	-0.73	+0.30
Martin ratio: Return relative to average drawdown	-0.80	-1.44	+0.64
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

RNAZ vs. BKNG - Sharpe Ratio Comparison

The current RNAZ Sharpe Ratio is -0.32, which is higher than the BKNG Sharpe Ratio of -0.76. The chart below compares the historical Sharpe Ratios of RNAZ and BKNG, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	RNAZ	BKNG	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.32	-0.76	+0.45
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.39	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.38	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.45	0.14	-0.59

Drawdowns

RNAZ vs. BKNG - Drawdown Comparison

The maximum RNAZ drawdown since its inception was -100.00%, roughly equal to the maximum BKNG drawdown of -99.32%. Use the drawdown chart below to compare losses from any high point for RNAZ and BKNG.

Drawdown Indicators

	RNAZ	BKNG	Difference
Max Drawdown Largest peak-to-trough decline	-100.00%	-99.32%	-0.68%
Max Drawdown (1Y) Largest decline over 1 year	-66.91%	-33.35%	-33.56%
Max Drawdown (3Y) Largest decline over 3 years	-100.00%	-33.35%	-66.65%
Max Drawdown (5Y) Largest decline over 5 years	—	-39.53%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-47.77%	—
Current Drawdown Current decline from peak	-100.00%	-28.75%	-71.25%
Average Drawdown Average peak-to-trough decline	-89.58%	-47.08%	-42.50%
Ulcer Index Depth and duration of drawdowns from previous peaks	35.57%	16.88%	+18.69%

Volatility

RNAZ vs. BKNG - Volatility Comparison

Transcode Therapeutics Inc (RNAZ) has a higher volatility of 20.54% compared to Booking Holdings Inc. (BKNG) at 9.21%. This indicates that RNAZ's price experiences larger fluctuations and is considered to be riskier than BKNG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	RNAZ	BKNG	Difference
Volatility (1M) Calculated over the trailing 1-month period	20.54%	9.21%	+11.33%
Volatility (6M) Calculated over the trailing 6-month period	60.96%	27.33%	+33.63%
Volatility (1Y) Calculated over the trailing 1-year period	89.14%	31.79%	+57.35%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	208.43%	32.22%	+176.21%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	208.43%	32.46%	+175.97%

Dividends

RNAZ vs. BKNG - Dividend Comparison

RNAZ has not paid dividends to shareholders, while BKNG's dividend yield for the trailing twelve months is around 0.95%.

Position	TTM	2025	2024
BKNG Booking Holdings Inc.	0.95%	0.72%	0.70%
RNAZ Transcode Therapeutics Inc	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both RNAZ and BKNG in my portfolio?

RNAZ and BKNG have a correlation of -0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, RNAZ or BKNG?

RNAZ has higher volatility (20.54%) compared to BKNG (9.21%). In terms of maximum drawdown, RNAZ dropped -100.00% vs BKNG's -99.32%.

Which has better risk-adjusted returns?

RNAZ currently has the higher Sharpe Ratio (-0.32 vs -0.76), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.